UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

       Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934

         Date of Report (date of earliest event reported): May 12, 2010


                               CAMELOT CORPORATION
               (Exact name of registrant as specified in charter)

         Colorado                       0-8299                   84-0691531
(State or other jurisdiction         (Commission               (IRS Employer
     of incorporation)               File Number)            Identification No.)

                        730 W. Randolph Street, Suite 600
                                Chicago, IL 60661
                    (Address of principal executive offices)

                                  312-454-0015
                           (Issuer's Telephone Number)

                                   Copies to:
                             Kristen A. Baracy, Esq.
                             Synergy Law Group, LLC
                       730 West Randolph Street, Suite 600
                                Chicago, IL 60661
                     Phone: 312-454-0015 - Fax: 312-454-0261

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))

                               CAMELOT CORPORATION

                           Current Report on Form 8-K

                                  May 12, 2010


ITEM 5.02  DEPARTURE OF DIRECTORS OR CERTAIN  OFFICERS;  ELECTION OF  DIRECTORS;
           APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF
           CERTAIN OFFICERS

On May 12, 2010, the sole director of Camelot Corporation (the "Company"), Danny
Wettreich,  appointed  Jeffrey Rochlin as a director of the Company.  Concurrent
with said appointment,  Mr. Wettreich  resigned as a director.  Mr. Rochlin owns
approximately  86.83% of the total issued and outstanding shares of common stock
of the Company and presently serves as the Company's President,  Chief Executive
Officer,  Chairman and  Treasurer.  Mr. Rochlin will serve as director until the
next  annual  meeting of  shareholders  and until his  successor  is elected and
qualified or his earlier removal or resignation.

JEFFREY ROCHLIN

Mr.  Rochlin,  40, is a resident of Washington  Township,  NJ, and a graduate of
University of Hartford, where he earned a degree in accounting. His professional
experience  has been primarily in the finance  sector,  where he has worked as a
finance manager in operations,  and senior accountant for a major pharmaceutical
company.  Currently,  he works for a biotechnology  company in its budgeting and
financial reporting sector.

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                          CAMELOT CORPORATION


May 12, 2010                              By /s/ Jeffrey Rochlin
                                             -----------------------------------
                                          Name:  Jeffrey Rochlin
                                          Title: President

                                       2